Global Cold Cardioplegia Infusion Device Market Growth 2024-2030

Global Cold Cardioplegia Infusion Device Market Growth 2024-2030

The cold cardioplegia infusion device is a medical device used in cardiac surgery. It can infuse cooled myocardial cardioplegia into the heart blood vessels to stop the heart for surgical operations. Myocardial cardioplegia is a special liquid that contains some ingredients that protect myocardial tissue, such as potassium, magnesium, antioxidants, etc., which can reduce myocardial ischemia and reperfusion injury and improve the success rate of surgery. The cryopreserve infusion device usually consists of a perfusion pump, a temperature controller, a bubble trap and a connecting tube, which can accurately control the flow, pressure and temperature of the perfusate to ensure that the myocardium is fully protected.

The global Cold Cardioplegia Infusion Device market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Cold Cardioplegia Infusion Device Industry Forecast” looks at past sales and reviews total world Cold Cardioplegia Infusion Device sales in 2023, providing a comprehensive analysis by region and market sector of projected Cold Cardioplegia Infusion Device sales for 2024 through 2030. With Cold Cardioplegia Infusion Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cold Cardioplegia Infusion Device industry.

This Insight Report provides a comprehensive analysis of the global Cold Cardioplegia Infusion Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cold Cardioplegia Infusion Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cold Cardioplegia Infusion Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cold Cardioplegia Infusion Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cold Cardioplegia Infusion Device.

United States market for Cold Cardioplegia Infusion Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Cold Cardioplegia Infusion Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Cold Cardioplegia Infusion Device is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Cold Cardioplegia Infusion Device players cover Medtronic, Boston Scientific, Terumo, Abbott Laboratories and B. Braun, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Cold Cardioplegia Infusion Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Pneumatic Cryoplegic Solution Infusion Device
Electromagnetic Cryoplegic Solution Infusion Device

Segmentation by application
Hospital
Clinic

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Boston Scientific
Terumo
Abbott Laboratories
B. Braun
Cook Medical
Cardinal Health
Teleflex
Merit Medical Systems
AngioDynamics
BD (Becton, Dickinson and Company)
Edwards Lifesciences
Cordis (a Cardinal Health company)
Stryker
Smiths Medical
Baxter International
LivaNova PLC
Sorin Group
Sartorius
Lonza Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cold Cardioplegia Infusion Device market?

What factors are driving Cold Cardioplegia Infusion Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cold Cardioplegia Infusion Device market opportunities vary by end market size?

How does Cold Cardioplegia Infusion Device break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.